Atormac
briv
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 22361  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
   Navigate here  
  Ľ   Search
  Ľ   Current Issue
  Ľ   Submit Article 
  Ľ   My Preferences 

Follow us on:

Twitter Icon Linkedin Icon Instagram Icon Facebook Icon

 


This article has been cited by
1Parkinson's disease in Nigeria: A review of published studies and recommendations for future research
Oluwafemi G. Oluwole,Helena Kuivaniemi,Jonathan A. Carr,Owen A. Ross,Matthew O.B. Olaogun,Soraya Bardien,Morenikeji A. Komolafe
Parkinsonism & Related Disorders.2019;62()36
[DOI]
2A New Approach to Assessing the Extent of Degradation of the Nigrostriatal Dopaminergic System in an Experimental Model of Parkinsonís Disease
V. V. Safandeev,M. V. Ugrumov
Neuroscience and Behavioral Physiology.2020;50(4)451
[DOI]
3Brain SPECT as a Biomarker of Neurodegeneration in Dementia in the Era of Molecular Imaging: Still a Valid Option?
Rodolfo Ferrando,Andres Damian
Frontiers in Neurology.2021;12(4)451
[DOI]
4Investigation of sensorimotor dysfunction in Parkinson disease by resting-state fMRI
Shuaiwen Wang,Yanli Zhang,Junqiang Lei,Shunlin Guo
Neuroscience Letters.2021;742(4)135512
[DOI]
5Multiparametric MR imaging of Parkinsonisms at 3 tesla: Its role in the differentiation of idiopathic Parkinsonís disease versus atypical Parkinsonian disorders
S.F. Calloni,G. Conte,S. Sbaraini,R. Cilia,V.E. Contarino,S. Avignone,G. Sacilotto,G. Pezzoli,F.M. Triulzi,E. Scola
European Journal of Radiology.2018;109(4)95
[DOI]
6Is Attention-Deficit/Hyperactivity Disorder a Risk Syndrome for Parkinsonís Disease?
Alan A. Baumeister
Harvard Review of Psychiatry.2021;Publish Ahead of Print(4)95
[DOI]
7Drug-Induced Parkinsonism
Kanwaljeet Garg,Roopa Rajan,Manmohan Singh
Neurology India.2021;69(2)437
[DOI]
Online since 20th March '04
Published by Wolters Kluwer - Medknow